Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Authors: Alan K. Burnett, Nigel H. Russell, Robert K. Hills, David Bowen, Jonathan Kell, Steven Knapper, Yvonne G Morgan, Jennie Lok, Angela Grech, Gail Jones, Asim Khwaja, Lone S. Friis, Mary Frances McMullin, Ann Hunter, Richard E Clark, David Grimwade - The Lancet 2015 cited by 543